Literature DB >> 17112897

The suppressive effect of resveratrol on protein kinase C theta in peripheral blood T lymphocytes in a rat liver transplantation model.

S-L Wu1, L Yu, X-Y Jiao, K-W Meng, C-E Pan.   

Abstract

UNLABELLED: Our aim was to study the effect of resveratrol on the expressions of protein kinase C isotypes (PKC alpha, theta) in peripheral blood lymphocytes and on the expression of IkappaB kinase-beta (IKK beta) in lymphocytes in allografts in a rat liver transplantation model.
METHODS: Orthotopic liver transplantations (OLT) were performed from Sprague Dawley rats to Wistar rats. The recipients were divided into two groups after OLT. In the RES group, resveratrol was given intraperitoneally once a day (100 mg kg(-1)) after OLT, whereas in the control group vehicle buffer was given. The expressions of PKC alpha, theta in peripheral blood lymphocytes, expression of IKK beta in lymphocytes in allograft, and survival periods were compared between the groups.
RESULTS: The mean survival period after OLT in the RES group was significantly longer than that in control group (P < .05). On posttransplant day 7, the expression of PKC theta in peripheral blood lymphocytes in the RES group was significantly decreased compared with that in the control group (P < .05), whereas there was no obvious difference in the expressions of PKC alpha between the two groups (P > .05), and the positive rate of IKK beta protein in lymphocytes in allografts in RES group was significantly decreased compared with that in the control group (P < .05).
CONCLUSION: Resveratrol showed an immunosuppressive effect on lymphocytes for allograft rejection in the rat. Down-regulation of the expression of PKC theta in peripheral blood lymphocytes may be part of the mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112897     DOI: 10.1016/j.transproceed.2006.08.150

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

Review 1.  Dietary agents in cancer prevention: an immunological perspective.

Authors:  Ya Ying Zheng; Bharathi Viswanathan; Pravin Kesarwani; Shikhar Mehrotra
Journal:  Photochem Photobiol       Date:  2012-03-30       Impact factor: 3.421

2.  Role of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice.

Authors:  Udai P Singh; Narendra P Singh; Balwan Singh; Lorne J Hofseth; Dennis D Taub; Robert L Price; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Brain Behav Immun       Date:  2011-07-23       Impact factor: 7.217

3.  Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes.

Authors:  S-M Lee; H Yang; D M Tartar; B Gao; X Luo; S Q Ye; H Zaghouani; D Fang
Journal:  Diabetologia       Date:  2011-02-22       Impact factor: 10.122

4.  Resveratrol Inhibits CD4+ T cell activation by enhancing the expression and activity of Sirt1.

Authors:  Ting Zou; Yi Yang; Fei Xia; Anfei Huang; Xiaoming Gao; Deyu Fang; Sidong Xiong; Jinping Zhang
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

5.  The suppressive effect of resveratrol on HIF-1α and VEGF expression after warm ischemia and reperfusion in rat liver.

Authors:  Mei Zhang; Wujun Li; Liang Yu; Shengli Wu
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

Review 6.  Herbal Medicines Attenuate PD-L1 Expression to Induce Anti-Proliferation in Obesity-Related Cancers.

Authors:  Yu-Chen S H Yang; Zi-Lin Li; Ya-Jung Shih; James A Bennett; Jaqueline Whang-Peng; Hung-Yun Lin; Paul J Davis; Kuan Wang
Journal:  Nutrients       Date:  2019-12-05       Impact factor: 5.717

7.  Oenothein B, a cyclic dimeric ellagitannin isolated from Epilobium angustifolium, enhances IFNγ production by lymphocytes.

Authors:  Andrew G Ramstead; Igor A Schepetkin; Mark T Quinn; Mark A Jutila
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 8.  Resveratrol and liver: A systematic review.

Authors:  Forouzan Faghihzadeh; Azita Hekmatdoost; Payman Adibi
Journal:  J Res Med Sci       Date:  2015-08       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.